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abstract
 
Mutations of the CFTR, a phosphorylation-regulated Cl
 
2
 
 channel, cause cystic ﬁbrosis. Activation of
CFTR by PKA stimulation appears to be mediated by a complex interaction between several consensus phosphory-
lation sites in the regulatory domain (R domain). None of these sites has a critical role in this process. Here, we
show that although endogenous phosphorylation by PKC is required for the effect of PKA on CFTR, stimulation
of PKC by itself has only a minor effect on human CFTR. In contrast, CFTR from the amphibians 
 
Necturus maculo-
sus 
 
and 
 
Xenopus
 
 
 
laevis 
 
(
 
X
 
CFTR) can be activated to similar degrees by stimulation of either PKA or PKC. Further-
more, the activation of 
 
X
 
CFTR by PKC is independent of the net charge of the R domain, and mutagenesis exper-
iments indicate that a single site (Thr
 
665
 
) is required for the activation of 
 
X
 
CFTR. Human CFTR lacks the PKC
phosphorylation consensus site that includes Thr
 
665
 
, but insertion of an equivalent site results in a large activation
upon PKC stimulation. These observations establish the presence of a novel mechanism of activation of CFTR by
phosphorylation of the R domain, i.e., activation by PKC requires a single consensus phosphorylation site and is
unrelated to the net charge of the R domain.
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INTRODUCTION
 
Cystic ﬁbrosis results from mutations in the CFTR, a
1,480–amino acid protein that functions as a Cl
 
2
 
-selec-
tive ion channel in a variety of epithelial cells. CFTR
has two topologically equivalent halves, each consisting
of a transmembrane domain (six membrane-spanning
helices) followed by a nucleotide-binding domain. The
cytoplasmic regulatory domain (R domain)
 
1
 
 links these
two halves. The membrane-spanning helices form the
anion-conductive pore, the nucleotide-binding domains
bind and hydrolyze ATP and are involved in channel
gating, and the R domain contains consensus phos-
phorylation sites for PKA and PKC (for review see Sei-
bert et al., 1997).
CFTR channels are gated by exposure to PKA and
ATP, both in excised patches and after puriﬁcation and
reconstitution in planar lipid bilayers (for review see
Seibert et al., 1997). Although it is well established that
phosphorylation of the R domain is essential for activa-
tion of CFTR, the precise molecular mechanism of this
activation has proven elusive, and is thought to involve
several sites and complex interactions (for reviews see
Chang et al., 1993; Gadsby and Nairn, 1999; Sheppard
and Welsh, 1999; Ma, 2000).
PKA-mediated activation of human CFTR (hCFTR)
requires endogenous phosphorylation by PKC (Cohn
et al., 1991; Jia et al., 1997; Vankeerberghen et al.,
1999). However, PKC-mediated phosphorylation, per
se, has only a small effect on hCFTR activity. In con-
trast, we discovered that 
 
Necturus
 
 CFTR can be activated
by either PKA- or PKC-mediated phosphorylation
(Copello et al., 1993). The same phenomenon occurs
with 
 
Xenopus 
 
CFTR (
 
X
 
CFTR), as shown in this study.
The goal of the present work was to determine the mo-
lecular bases for the differences in the activation of
hCFTR and 
 
X
 
CFTR by PKC stimulation. Our results
show that, in contrast with the complexity of PKA-medi-
ated activation, the stimulation of 
 
X
 
CFTR by PKC de-
pends on a single PKC consensus phosphorylation site in
the R domain. Conﬁrming the importance of the critical
site in 
 
X
 
CFTR, engineering an equivalent site in hCFTR
makes this molecule responsive to PKC stimulation.
 
MATERIALS AND METHODS
 
cRNA Preparation
 
Full-length hCFTR and 
 
X
 
CFTR cDNAs were subcloned into the
oocyte expression vector pOCYT7 (gift from Dr. Nancy Wills, Uni-
versity of Texas Medical Branch; Mo et al., 1999). This expression
 
vector contains the 
 
Xenopus
 
 5
 
9
 
 and 3
 
9
 
 
 
b
 
-globin untranslated re-
gions to boost expression in oocytes (Mo et al., 1999). In brief,
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human CFTR (a gift from Dr. Lap-Chee Tsui, The Hospital for
Sick Children, Toronto, Canada), was cut with XmaI and SalI and
ligated into pOCTY7 cut with the same restriction enzymes. 
 
Xeno-
pus
 
 CFTR (a gift from Drs. Margaret Price and Michael Welsh,
University of Iowa, Iowa City, IA; Price et al., 1996), was cloned
into the KpnI and SalI sites of pOCYT7. The resulting vectors
were linearized with XhoI and used as templates for T7-directed
capped cRNA synthesis (mMessage mMachine; Ambion).
 
Oocyte Preparation and cRNA Injection
 
Xenopus laevis 
 
oocytes were isolated and prepared using a well-
documented protocol (Sharon et al., 1997). In brief, ovarian
lobes were surgically removed from frogs anesthetized with tri-
caine methanesulfonate (1 g/liter). Stage-V and -VI oocytes were
isolated by manual dissection and defolliculated using enzymatic
treatment with 1 mg/ml type I collagenase in Barth’s solution
([in mM] 88 NaCl, 1.0 KCl, 1.0 CaCl
 
2
 
, 1.0 MgCl
 
2
 
, and 10 HEPES/
NaOH, pH 7.40) containing 10 
 
m
 
g/ml penicillin, 10 
 
m
 
g/ml
streptomycin, and 100 
 
m
 
g/ml gentamicin sulfate, for 16 h (all in-
cubations were performed at 16
 
8
 
C). The enzymatic treatment
was followed by a 2-h incubation in calcium-free Barth’s solution.
Treated oocytes were transferred to Barth’s solution. Oocytes
were injected with 47 nl of CFTR cRNA (5–10 ng) or sterile water
24–72 h before analysis, using a Nanoject autoinjector (Drum-
mond Scientiﬁc). The 8-Br-cAMP–activated currents in the mu-
tant H667R-hCFTR were very high; thus, cRNA injection was re-
duced to 1–2.5 ng/oocyte.
 
Two-electrode Voltage Clamp
 
Oocytes were bathed in the HEPES-buffered solution ND96 ([in
mM] 96 NaCl, 2 KCl, 1.0 MgCl
 
2
 
, 1.8 CaCl
 
2
 
, and 5 HEPES/NaOH,
pH 7.40). All experiments were performed at 22–24
 
8
 
C. Borosili-
cate microelectrodes were pulled with a horizontal puller (P-97;
Sutter Instruments), ﬁlled with 3 M KCl, and had tip resistances
of 0.5–1.5 M
 
V
 
 when immersed in ND96 solution. A voltage-
clamp ampliﬁer (model OC-725C; Warner Instruments) was used
to measure whole-oocyte conductance. Voltages were referenced
to the bath. Membrane currents were ﬁltered at 1.0 kHz, digi-
tized, stored, and analyzed with pCLAMP version 8.0 (Axon In-
struments). I-V relationships were obtained by current measure-
ments 400 ms after changing the potential from a holding value
of 
 
2
 
30 mV to test values ranging from 
 
2
 
100 to 
 
1
 
30 mV, in 10-
mV steps, with 100-ms intervals between pulses. Oocyte conduc-
tance was determined in the consistently linear range between
the reversal potential and 30 mV. The membrane conductances
of unstimulated oocytes (i.e., no 8-Br-cAMP or PMA) after cRNA
injection were not different from those of water-injected oocytes
(Table I). In hCFTR- and 
 
X
 
CFTR-expressing oocytes, membrane
conductances were directly proportional to the amount of cRNA
injected (not shown) and time after injection (Table I). In all ex-
 
periments detailed here, supra-maximal concentrations of either
cAMP cocktail (250 
 
m
 
M 8-Br-cAMP and 25 
 
m
 
M forskolin) or PMA
(250 nM) were used to stimulate maximally PKA or PKC, respec-
tively. For the time course experiments, differences between the
current at 
 
2
 
30 mV (the holding potential) and 0 mV were mea-
sured every 5 s. Halide selectivity sequences were determined
from the changes in reversal potential after substituting NaCl
with the corresponding sodium-halide salt for 2 min before the
I-V plots. Corrections for liquid junction potentials were as previ-
ously described (Vanoye et al., 1997).
 
Whole-cell Patch Clamp
 
Whole cell patch-clamp studies were performed essentially as
previously described (Vanoye et al., 1997). COS-1 cells transiently
transfected with hCFTR or 
 
X
 
CFTR cDNA into the pTracer-CMV
vector (Invitrogen) were studied after 2–3 d. The bath solution
contained (in mM): 140 NMDG, 0.5 MgCl
 
2
 
, 1.3 CaCl
 
2
 
, and 10
HEPES/NaOH, pH 7.4. The pipet solution contained (in mM):
140 NMDG, 1.2 MgCl
 
2
 
, 1 EGTA, 2 ATP 10 mM HEPES/NaOH,
pH 7.2. Patch pipets (2–4 M
 
V
 
 tip resistance in nearly symmetric
NMDG-Cl) were pulled with a horizontal pipet puller (model
P-97; Sutter Instruments). Negative pressure was used to rupture
the membrane patch after obtaining a gigaohm seal, and cur-
rents were measured in the whole-cell conﬁguration with an am-
pliﬁer (model Axopatch 200A; Axon Instruments). The holding
voltage (V
 
m
 
) was 
 
2
 
60 mV. I-V relationships were constructed us-
ing 400-ms voltage pulses between 
 
2
 
80 to 
 
1
 
80 mV, at 10-mV in-
tervals. PClamp6 (Axon Instruments) was used for generation of
the pulses, data collection, and analysis.
 
Human-Xenopus R Domain Chimera Construction
 
A chimera, in which residues 607–811 of the hCFTR were re-
placed by the corresponding 
 
X
 
CFTR residues, was engineered by
a combination of site-directed mutagenesis and PCR. Site-
directed mutagenesis was used to introduce MluI and KasI
unique sites at the 5
 
9
 
 and 3
 
9
 
 ends of the R domain hCFTR cDNA se-
quence with silent mutations. The QuickChange site-directed
mutagenesis kit (Stratagene) was used to insert the unique re-
striction sites. Two mutagenic oligonucleotide primers, each
complementary to opposite strands of the vector, were used for
each mutagenesis reaction. The wild-type hCFTR was used as a
template. The primers used were as follows (only sense primer is
shown, restriction sites underlined): 5
 
9
 
-TGGCTAACAAAACGCG-
TATTTTGGTCAC-3
 
9
 
 (MluI site) and 5
 
9
 
-GGATATATATTCAAG-
GCGCCTATCTCAAGAAAC-3
 
9
 
 (KasI site). The reaction mixture
was heated at 95
 
8
 
C for 45 s and subjected to 12 cycles for 30 s at
95
 
8
 
C, 30 s at 55
 
8
 
C, and 10 min at 72
 
8
 
C. Cycling was ﬁnished by a
10-min incubation at 70
 
8
 
C. The PCR reaction was treated with
DpnI to digest the DNA template, and then used to transform
 
Escherichia coli
 
. The 
 
X
 
CFTR R domain cDNA was ampliﬁed by PCR,
introducing MluI and KasI sites that were used to exchange the
hCFTR and 
 
X
 
CFTR R domain sequences. The PCR primers were
as follows (MluI and KasI sites underlined): 5
 
9
 
-GGGACGCG-
TATTTTAGTTACATCT AAAGTCG-3
 
9
 
 (forward) and 5
 
9
 
-TTT-
GAAGTGGATATATATAATAGGCGCCGCG-3
 
9
 
 (reverse).
 
PKC Consensus Site Mutagenesis
 
The QuickChange site-directed mutagenesis kit was used, as de-
scribed above, to make point mutations. To remove consensus
phosphorylation sites, Ser or Thr were substituted with Ala. The
primers also contained silent mutations to introduce unique re-
striction sites for primary screening. The following primers were
used (only sense primer is shown, with mutations underlined):
5
 
9
 
-TAATAACTGAGGCCCTGAGACGATGCT-3
 
9
 
 (Thr
 
665
 
 to Ala,
 
TABLE I
 
Conductances of Xenopus Oocytes Expressing CFTR
 
Unstimulated cAMP-stimulated
 
24 h 48 h 72 h
 
Mock 2.9 
 
6
 
 1.7 (11)  2.7 
 
6
 
 1.4 (4) 2.9 
 
6
 
 1.6 (4) 3.2 
 
6
 
 2.1 (3)
hCFTR 4.2 
 
6
 
 3.8 (35) 426 
 
6
 
 60 (16)  685 
 
6
 
 131 (13) 1,147 
 
6
 
 217 (6)
 
X
 
CFTR 3.1 
 
6
 
 2.1 (34) 214 
 
6
 
 50 (14) 1,009 
 
6
 
 268 (14) 2,028 
 
6
 
 217 (6)
 
Xenopus laevis
 
 oocytes were injected with water (mock), hCFTR cRNA, or
 
X
 
CFTR cRNA, and their membrane conductances were measured at 24,
48, or 72 h after injection with and without stimulation with cAMP cocktail.
Conductances are expressed in microSiemens. Each result represents the
mean 
 
6
 
 SEM of 
 
n
 
 experiments (numbers in parentheses). 
459
 
Button et al.
 
 
 
plus addition of HaeIII site), 5
 
9
 
-GTCAAGAATAAAGCTTTTAAG-
CAGG-3
 
9
 
 (Ser
 
686
 
 to Ala, plus addition of HindIII site), 5
 
9
 
-TGGG-
GATTTCGCTGAGAAAAGAAAGAG-3
 
9
 
 (Ser
 
694
 
 to Ala, plus ad-
dition of DdeI site), and 5
 
9
 
-CAAGAAAAACTGCAGTTCG-
TAAAATG-3
 
9
 
 (Ser
 
790
 
 to Ala, plus addition of PstI site). For
construction of the H667R-hCFTR mutant, the primer used was
5
 
9
 
-AGACCTTGCGCCGTTTCTCA-3
 
9
 
 (construct screened with
HhaI, underlined). The wild-type 
 
X
 
CFTR or hCFTR in the
pOCYT7 vector (see above) was used as a template. 
 
Oocyte cAMP Levels
 
Intracellular cAMP was determined 24–48 h after cRNA injection.
Oocytes were incubated for 20 min in the presence of either 250
nM PMA to activate PKC or 25 
 
m
 
M forskolin to activate PKA. At
the end of the incubation period, cells were lysed by sonication.
All samples were heated to 95
 
8
 
C for 5 min and centrifuged at
12,000 
 
g
 
 for 15 min at 4
 
8
 
C. The supernatants were assayed using a
cAMP enzyme immunoassay kit (Amersham Pharmacia Biotech).
 
Western Blot Analysis
 
Western blot analysis was performed with the afﬁnity-puriﬁed
rabbit anti-CFTR antibody 
 
a
 
1468 (provided by Dr. Jonathan
Cohn, Duke University, Durham, NC; Cohn et al., 1991; Torres et
 
al., 1996). The epitope consists of the COOH-terminal 13 amino
acids of human CFTR. The last 12 amino acids are identical in
hCFTR and 
 
X
 
CFTR. Enriched plasma membranes were prepared
by membrane biotinylation and streptavidin afﬁnity puriﬁcation
(Pajor et al., 1998). In brief, membrane proteins were labeled by
incubating the oocytes with 0.5 mg/ml biotin (EZ-Link Sulfo-
NHS-Biotin; Pierce Chemical Co.) for 30 min at room tempera-
ture in Barth’s solution. Oocytes were washed three times with 4
ml of ice-cold PBS to remove unbound biotin, resuspended in
Barth’s solution, and lysed at 4
 
8
 
C by sonication with an ultrasonic
processor (model GE501; Sonics and Materials). Yolk and de-
bris were collected by centrifugation at 1,000 g for 5 min at 48C.
The supernatant was gently mixed for 1 h at 48C with 50 ml of
streptavidin attached to beads (ImmunoPure immobilized
streptavidin; Pierce Chemical Co.). Bound membranes were col-
lected by centrifugation at 1,000 g for 2 min at 48C. The pellet
was washed twice with PBS, resuspended in electrophoresis sam-
ple buffer, and subjected to 10% SDS-PAGE electrophoresis
(NuPage Bis-Tris; Novex). Western blots were performed as pre-
viously described (Han et al., 1996). The primary antibody con-
centration was 1 mg/ml, and the secondary antibody was a
horseradish peroxidase goat anti–rabbit. CFTR detection was
performed by enhanced chemiluminescence (Amersham Phar-
macia Biotech).
Figure 1. Activation of CFTR Cl2 conductance by PKA
stimulation. The two-electrode voltage-clamp technique
was used to measure ionic currents before and z30 min
after exposure to a cAMP cocktail consisting of 250 mM
8-Br-cAMP and 25 mM forskolin (cAMP). (A) Representa-
tive currents obtained in water-injected oocytes and oo-
cytes expressing hCFTR or XCFTR. (B) Time course of
hCFTR and XCFTR activation by cAMP. DI is the current
measured at 0 mV minus the current at 230 mV (holding
potential). (C) Halide-selectivity sequence of cAMP-acti-
vated hCFTR. I-V relationships were obtained from an oo-
cyte in the constant presence of cAMP cocktail by substi-
tuting NaCl in each solution with the corresponding so-
dium halide salt for 2 min before the I-V plots. Currents
were measured at 400 ms after the start of voltage pulses
ranging from 2100 to 30 mV at 10-mV intervals. (D) Ha-
lide-selectivity sequence obtained from a XCFTR-express-
ing oocyte. Injection of hCFTR and XCFTR cRNAs elicits
anion currents with the expected halide selectivity.460 Regulation of CFTR by PKC-mediated Phosphorylation
Solutions and Drugs
To activate PKA, intracellular cAMP was elevated using a cAMP
cocktail containing 250 mM 8-Br-cAMP and 25 mM forskolin
(Sigma-Aldrich). To activate PKC, 250 nM PMA (Sigma-Aldrich)
was added to the bath. Stock solutions of these compounds were
prepared in water (8-Br-cAMP), dimethylsulfoxide (PMA), or
ethanol (forskolin), and diluted to the desired ﬁnal concentra-
tion in ND96 solution immediately before use. At the concentra-
tions used, the vehicles had no effects on the CFTR currents.
Statistical Analysis
Data are expressed as the means 6 SEM. Differences between
means were compared by either paired or unpaired two-tailed t
tests, as appropriate. Statistical signiﬁcance was ascribed to P ,
0.05.
RESULTS
Differential Activation of Human and Xenopus 
CFTR by PKC
We expressed human and Xenopus CFTR orthologues in
Xenopus oocytes because these cells are capable of appro-
priate posttranslational processing, express CFTR at high
levels, and have no signiﬁcant endogenous cAMP- or
PMA-activated Cl2 currents (Cunningham et al., 1992).
Injection of either human or Xenopus CFTR cRNA into
Xenopus oocytes resulted in functional CFTR expression
in the plasma membrane, as shown by the stimulation of
CFTR chloride currents in response to 8-Br-cAMP and
forskolin (Fig. 1). The current in water-injected oocytes
was insensitive to PKA agonists (Fig. 1 A; Bear et al., 1991;
Yamazaki et al., 1999). The currents are mediated by
CFTR based on their halide selectivities (i.e., Br2 < Cl2 .
I2  . F 2 for hCFTR and I2  . Cl2  . Br2  . F 2 for
XCFTR [Fig. 1, C and D]), and their reversal potentials
(in NaCl-based bath solution) near the Cl2 equilibrium
potential (about 230 mV; Cunningham et al., 1992).
To determine the effect of PKC-mediated phosphory-
lation on the activation of the two CFTR orthologues,
oocytes expressing hCFTR or XCFTR were exposed to
PMA. I-V relationships, current time course, and con-
ductance data in Fig. 2 show that, in hCFTR-expressing
oocytes, PMA alone elicits only a small fraction of the
conductance observed after the subsequent application
of the cAMP cocktail. Exposure to PMA resulted, as
previously observed by others (Berger et al., 1993;
Yamazaki et al., 1999), in a transient hCFTR conduc-
tance (Fig. 2 C) that amounted to 28 6 7%, followed by
a sustained conductance of only 13 6 3% of the total
conductance observed with stimulation of both PKC
and PKA (Fig. 2 A, C, and E). Higher PMA concentra-
tions did not increase the currents further. Relative to
the current elicited by 250 nM PMA, the current after
500 nM PMA was 103 6 5% (n 5 4), and after 1 mM it
was 89 6 9% (n 5 2).
In contrast, in XCFTR-expressing oocytes, PMA acti-
vated 79 6 8% of the conductance seen after stimula-
Figure 2. Activation of CFTR Cl2 conductance by PKC. (A) Rep-
resentative I-V plot obtained from an oocyte injected with hCFTR.
(B) I-V plot obtained from an oocyte injected with XCFTR. (C)
Time course of hCFTR activation by PMA. (D) Time course of
XCFTR activation by PMA. (E) Summary of the maximal conduc-
tance elicited by PMA. Data were normalized to the maximal con-
ductance obtained with PMA 1 cAMP. Data shown are from 10 to
12 hCFTR- and XCFTR-expressing oocytes, respectively. I-V plots
in PMA-treated oocytes were obtained approximately 15 min after
exposure to 250 nM PMA. Next, the cells were exposed to the
cAMP cocktail in the continuous presence of PMA, and I-V plots
were recorded approximately 10 min later. The results show that
PMA is highly effective in activating XCFTR, but not hCFTR. See
Fig. 1 for additional details.
Figure 3. Effects of PMA and forskolin on cAMP levels. Data are
from unstimulated oocytes and oocytes exposed for 20 min to either
PMA (250 nM) or forskolin (25 mM). Forskolin, but not PMA, in-
creased oocytes cAMP (P , 0.01, n 5 3 for each group of oocytes).461 Button et al. 
tion of both PKA and PKC (Fig. 2, B, D, and E). The
PMA-activated conductance was sustained for over 30
min, in the continued presence of PMA, and was revers-
ible after extended washout, like the XCFTR conduc-
tance elicited by PKA stimulation (not shown). In these
experiments, higher 8-Br-cAMP concentrations did not
increase the currents further. Relative to the current
elicited by 250 mM 8-Br-cAMP, the current after 500 mM
8-Br-cAMP was 98 6 12% (n 5 3), and after 1 mM 8-Br-
cAMP it was 96 6 2% (n 5 3).
The above results demonstrate that exposure to PMA
activates XCFTR to a level similar to that obtained after
PKA stimulation. To determine whether the effect of
PMA is due to activation of PKC, we tested the inactive
phorbol analogue 4a-PMA on XCFTR-expressing oo-
cytes. Application of 4a-PMA (250 nM) did not change
oocyte membrane conductance, whereas subsequent
exposure to 4b-PMA caused an increase in conductance
to 86 6 11% of the value after exposure to the cAMP
cocktail and 4b-PMA combined, similar to the results in
Fig. 2. Further, application of 4b-PMA to water- or
hCFTR-injected oocytes, as well as application of 4a-
PMA after 4b-PMA in the XCFTR-injected oocytes, had
no effect on the oocyte conductances (data not shown).
Another possibility is that PMA increases XCFTR con-
ductance via an elevation of cAMP. Cross-talk between
the PKA and PKC signaling systems has been demon-
strated in a number of systems (Gao et al., 1999). To ex-
plain our data, the cross-talk would have to take place
in XCFTR-, but not in hCFTR-expressing oocytes. To
test this possibility, intracellular cAMP was measured
under control conditions (in ND96 medium) and after
exposure to either 250 nM PMA or 25 mM forskolin. As
seen in Fig. 3, a 20-min exposure to PMA did not in-
crease intracellular cAMP in oocytes injected with water
or expressing either hCFTR or XCFTR. In contrast, for-
skolin increased Xenopus oocytes intracellular cAMP
level by more than 80-fold.
Finally, the difference between hCFTR and XCFTR
sensitivity to PMA could be in principle explained by
the expression system used. One or more cell-speciﬁc
components in Xenopus oocytes could allow XCFTR,
but not hCFTR, to be directly or indirectly sensitive to
PKC-mediated phosphorylation. This question was ad-
dressed by experiments in which either XCFTR or
hCFTR was expressed in COS-1 cells. In four experi-
ments in cells transfected with XCFTR cDNA, PMA elic-
ited a conductance of 55 6 3% of that produced by
8-Br-cAMP or forskolin.2 In contrast, in COS-1 cells ex-
pressing hCFTR, the increase in conductance elicited
by PMA was on average 21 6 4%. Taken together, the
experiments in Xenopus oocytes and COS-1 cells dem-
onstrate that the difference in PKC-mediated activation
of human and Xenopus orthologues is inherent to the
CFTR molecules and not to the host cells.
2In one experiment, there was no response to PMA. If this experi-
ment is included in the calculation, the PMA-stimulated conductance
is still significantly increased, i.e., 47 6 4% of the 8-Br-cAMP-stimu-
lated current. A negative result was also observed in 1 of 16 experi-
ments in Xenopus oocytes expressing XCFTR. A possible explanation
for the occasional absence of response to PMA is that the cells had
low endogenous cAMP levels (see next page).
Figure 4. Alignment of the sequences of hu-
man,  Xenopus and Necturus CFTR R domains. The
number below each consensus sequence refers to
the Ser/Thr position of the full-length hCFTR se-
quence. Arrows above indicate that the labeled
residue has been shown to be phosphorylated by
either PKA or PKC in human CFTR (Cheng et al.,
1991; Picciotto et al., 1992).462 Regulation of CFTR by PKC-mediated Phosphorylation
The R Domain Accounts for the Differences in the Responses of 
Human and Xenopus CFTR to PKC Activation
To test for a possible role of the R domain, a chimera
was constructed in which residues 607– 811 of hCFTR
(Figs. 4 and 5 A) were replaced with the equivalent res-
idues of XCFTR. This chimera (HXH-CFTR) contains
the NH2- and COOH-terminal transmembrane do-
mains and nucleotide-binding domains from hCFTR.
It should exhibit the halide-selectivity sequence of
hCFTR, because previous experiments with human/Xe-
nopus chimeras revealed that the halide selectivity se-
quence of hCFTR and XCFTR depends on the NH2-ter-
minal transmembrane domain (Price et al., 1996). In
addition, if the R domain from XCFTR is the region re-
sponsible for the regulation by PKC-mediated phos-
phorylation, then HXH-CFTR should be sensitive to
PKC agonists, like XCFTR.
HXH-CFTR was fully processed and inserted in the
plasma membranes of Xenopus oocytes as shown by
Western blot analysis of plasma membranes (Fig. 5 B).
Electrophysiological studies showed no appreciable
current in the absence of kinase stimulation (Figs. 5 C
and 6 A), as shown above for wild-type hCFTR and
XCFTR (Figs. 1 and 2). The PKA agonist 8-Br-cAMP re-
versibly elicited a large, near-linear current, with a re-
versal potential of approximately 230 mV (Fig. 6, A
and C) and halide-selectivity sequence identical to that
of wild-type hCFTR (Fig. 5 D).
The response to PMA of oocytes expressing HXH-
CFTR was similar to those of oocytes expressing either
hCFTR or XCFTR, in a clearly bimodal distribution,
Figure 5. Design and expression of the human-Xenopus chi-
mera (HXH-CFTR). (A) Schematic representation of hCFTR,
XCFTR, and HXH-CFTR, showing the location of the membrane-
spanning domain (MSD), nucleotide-binding domain (NBD),
and the R domain. (B) Plasma membrane expression of hCFTR,
XCFTR, and HXH-CFTR chimera. Western blots of biotinylated
membranes injected with water [C], HXH-CFTR [HXH], hCFTR
[H], or XCFTR [X]; there were ﬁve oocytes per condition. The
arrow denotes the expected size of full-length CFTR (z170 kD).
(C) Representative currents from an oocyte expressing HXH-
CFTR. (D) Halide selectivity sequences of cAMP-activated HXH-
CFTR. The results show that PKA stimulation elicits a near-linear
current with reversal potential near ECl and halide selectivity
identical to that of wild-type hCFTR (Br2 5 Cl2 . I2 . F2). See
Fig. 1 for additional details.
Figure 6. Stimulation of HXH-CFTR by PKC-mediated phosphor-
ylation. (A) I-V plot from an oocyte expressing HXH-CFTR. (B) I-V
plot from an oocyte expressing hCFTR. (C) Time course of HXH-
CFTR activation by PMA. Priming denotes the addition of 50 mM
8-Br-cAMP. (D) Comparison of CFTR activation by PMA in oocytes
expressing either wild-type hCFTR or XCFTR, or the HXH-CFTR
chimera. Data were obtained in oocytes primed with 50 mM cAMP
(see text), and were normalized to the current elicited by PMA and
cAMP cocktail together. Data shown are from 12, 12, and 15 experi-
ments in hCFTR-, XCFTR-, and HXH-CFTR-expressing oocytes, re-
spectively. The results show that the HXH-CFTR chimera is fully sen-
sitive to PMA stimulation. See Fig. 1 for additional details.463 Button et al. 
without intermediate responses. A basal level of PKA-
mediated phosphorylation, insufﬁcient to activate
XCFTR by itself, is required for the PMA effect
(Yamazaki et al., 1999; Button et al., 2000). Since oo-
cyte endogenous cAMP levels from oocyte to oocyte
(on average 300 nmol/oocyte) are quite variable, we
reasoned that the variability in activation of HXH-CFTR
by PMA alone could result from differences in intracel-
lular cAMP. In oocytes with low PKA activity, HXH-
CFTR may not be phosphorylated enough to be acti-
vated by PMA alone. To “standardize” the level of PKA
activity, we exposed the cells to 8-Br-cAMP at a concen-
tration insufﬁcient to activate the current by itself (Fig.
6). We call this “priming.” In all 15 experiments, appli-
cation of PMA to primed oocytes expressing HXH-
CFTR elicited full current activation (102 6 8% of the
current observed with the subsequent addition of the
cAMP cocktail; Fig. 6, A and C), which is not different
from the results in oocytes expressing wild-type XCFTR
(Fig. 2 C). However, priming did not increase the acti-
vation of the wild-type hCFTR by PKC-mediated phos-
phorylation (Fig. 6, B and C). From these results, we
conclude that the R domain is the target for the activa-
tion of XCFTR by PKC stimulation, and that the Xeno-
pus R domain is sufﬁcient to confer the sensitivity of
CFTR to PKC stimulation.
Conserved Phosphorylation Sites Are Not Involved in the 
Response to PKC Activation
As shown in Fig. 4, the R domain of XCFTR contains at
least seven consensus sites for phosphorylation by PKC.
Four of the phosphorylatable residues are also present
in hCFTR (Thr605, Ser686, Ser707, and Ser790), and two of
them (Ser686 and Ser790) are phosphorylated in vitro in
hCFTR (Picciotto et al., 1992). The R domain of
XCFTR contains two additional sites (Thr665 and Ser694)
also present in the N. maculosus CFTR homologue, but
absent in hCFTR (Fig. 4). Like the Xenopus CFTR, the
PKC agonist PMA activates the Necturus homologue of
CFTR (Copello et al., 1993). The role of the “con-
served” and “unique” phosphorylation sites in the stim-
ulation of XCFTR by PMA was explored by substituting
serine or threonine of the consensus sequences with
alanine. In these experiments, priming was carried out
as explained above.
Substitution of the two conserved serine residues
known to be phosphorylated (Ser686 and Ser790; Pic-
ciotto et al., 1992) with alanine residues (S686A/
S790A-XCFTR; Fig. 7, A and C) did not affect the activa-
tion by PMA. The unstimulated oocytes displayed no
signiﬁcant current, and the subsequent application of
8-Br-cAMP elicited a large, linear, reversible current,
with a reversal potential close to ECl (approximately
230 mV; Fig. 7 A) and a halide-selectivity sequence
identical to that of XCFTR (I2 . Cl2 . Br2 . F2; Fig. 1
C). These results indicate that the currents are medi-
ated by CFTR, and agree with the notion that the ion
pore is formed by the transmembrane segments (Price
et al., 1996). In seven experiments, PMA stimulated the
current to 92 6 11% of the response to the combina-
tion of 8-Br-cAMP and PMA (Fig. 7, A and C). This ob-
servation indicates that Ser686 and Ser790 are not neces-
sary for the activation of XCFTR by PKC stimulation.
Thr665 Is Essential for the Response to PKC 
Activation of XCFTR
To investigate the roles of the unique PKC consensus
sites (Thr665 and Ser694), we expressed the mutant lack-
ing both sites (T665A/S694A-XCFTR) in Xenopus oo-
cytes. This mutant was also well expressed, did not ex-
hibit basal current, and was sensitive to agonists of PKA-
mediated phosphorylation (Fig. 7 B). However, PMA
elicited a small current (Fig. 7, B and C) that was not dif-
ferent from that measured in oocytes expressing wild-
type hCFTR. The lack of response to PMA could not be
overcome by a higher concentration (750 nM, data not
shown). This result suggests that at least one of the two
unique sites in the R domain of XCFTR is critical for acti-
vation by PKC-mediated phosphorylation. Although the
degrees of activation of this mutant by PKA and PKC
were the same as in the wild-type hCFTR, its halide-selec-
Figure 7. Knockout of the unique PKC consensus phosphoryla-
tion sites prevents full activation of XCFTR by PMA. (A) Represen-
tative I-V relationships from an oocyte expressing the double
knockout of conserved PKC consensus phosphorylation sites
(S686A/S790A-XCFTR). (B) I-V plot from a cell expressing the
double knockout of unique PKC consensus phosphorylation sites
(T665A/S694A-XCFTR). (C) Summary of results from experiments
identical to those in A (n 5 4) and B (n 5 6). The results indicate
that at least one of the conserved PKC consensus sites is necessary
for full activation by PMA. See Figs. 1 and 2 for additional details.464 Regulation of CFTR by PKC-mediated Phosphorylation
tivity sequence (I2 . Cl2 . Br2 . F2; Fig. 1) was identi-
cal to that of the wild-type XCFTR, as expected.
To ascertain the roles of the two conserved sites, we
mutated Thr665 and Ser694 separately and tested the ef-
fect of PMA in primed oocytes. When S694A-XCFTR
was stimulated with PMA, there was full current activa-
tion (Fig. 8, A and C). In contrast, in oocytes express-
ing T665A-XCFTR, PMA failed to produce full current
activation (Fig. 8, B and C). Currents in cRNA-injected
oocytes vary from cell to cell. Thus, it is possible that
the reduced activation by PMA of XCFTR mutants con-
taining the Thr665 to Ala mutation is not absolute, but
relative to the activation by PKA stimulation (i.e., the
mutation increases the activation of CFTR by cAMP).
The data in Fig. 9 indicate that this is not the case be-
cause the cAMP-activated currents are not different
among oocytes expressing wild-type XCFTR, S686A/
S790A-XCFTR, or T665A/S694A-XCFTR. These results
prove that Thr665 is the residue necessary for the activa-
tion of CFTR by PKC.
Engineering a PKC Consensus Phosphorylation Site that 
Includes Thr665 Confers PKC-sensitivity to hCFTR
The hCFTR is unique among all known CFTR homo-
logues in that it lacks a PKC consensus site at the loca-
tion equivalent to residue 665 in XCFTR. As shown in
Fig. 4, this is due to the presence of His667 instead of
arginine or lysine. Since Thr665 is present in hCFTR, we
decided to determine whether the formation of a PKC
consensus phosphorylation site in hCFTR by substitut-
ing His with Arg at position 667 is sufﬁcient to confer
the Xenopus phenotype to hCFTR. The mutant H667R-
hCFTR was expressed in Xenopus oocytes and tested for
activation by PKC stimulation. In oocytes primed with
8-Br-cAMP, as described above, PMA produced a large
activation of the conductance, amounting to 68 6 6%
(n 5 6) of the current elicited by the combination of
PMA and cAMP cocktail (Fig. 10). The PMA-depen-
dent conductance in the presence of priming was sig-
niﬁcantly greater than that in wild-type hCFTR, al-
though perhaps smaller than the analogous value in
HXH-CFTR. This demonstrates that the phosphoryla-
tion site at Thr665 is sufﬁcient to explain CFTR activa-
tion by PKC-mediated phosphorylation.
DISCUSSION
The phosphorylation of serines and threonines by
cAMP-dependent kinases is a conserved step in the acti-
vation of CFTR Cl2 channels from several species (Sei-
bert et al., 1997). It is clear that at least four of the diba-
sic PKA consensus sites in the R domain are important
for activation (Chang et al., 1993; Rich et al., 1993).
PKC stimulation alone produced only a small activa-
tion of hCFTR expressed in Xenopus oocytes, a result
consistent with those previously reported using either
heterologous expression systems or native CFTR-
expressing cells (Berger et al., 1993; Yamazaki et al.,
1999). In contrast, PKC stimulation of XCFTR elicited a
large Cl2 conductance, similar in magnitude to that ac-
tivated by PKA agonists. Further, experiments with ex-
pression of either hCFTR or XCFTR in COS-1 cells
yielded similar results to those in Xenopus oocytes.
Thus, activation of CFTR by PKC is a property of the
amphibian CFTR isoforms.
Figure 8. Thr665 is critical for activation of XCFTR by PKC-medi-
ated phosphorylation. (A) Representative I-V plot from an oocyte
expressing a single knockout of the unique PKC consensus phos-
phorylation site containing Ser694 (S694A-XCFTR). (B) I-V plot
from an oocyte expressing a single knockout of the unique PKC
consensus phosphorylation site containing Thr665 (Thr665/A-
XCFTR). (C) Summary of results from experiments identical to
those in A (n 5 6) and B (n 5 14). The results denote a critical
role of Thr665 in the stimulation of XCFTR by PMA. See Figs. 1 and
2 for additional details.
Figure 9. The mutation Thr665 to Ala does not increase cAMP-
activated XCFTR currents. Time course of the currents after stimu-
lation with the cAMP cocktail in oocytes injected with wild-type
XCFTR, S686A/S790A-XCFTR, or T665A/S694A-XCFTR cRNAs.
Currents were measured at 30 mV, 20 min after exposure to the
cAMP cocktail. The data show that the Thr665 to Ala mutation has
no signiﬁcant effect on the level of cAMP-activated currents.465 Button et al. 
A Single PKC Consensus Phosphorylation Site in the R 
Domain Is Needed for the Activation of Xenopus CFTR 
by PKC Stimulation
The chimera in which the R domain of XCFTR re-
placed the R domain of hCFTR exhibited the halide-
selectivity sequence of hCFTR, as expected from previous
studies indicating that the ion selectivity of CFTR is de-
termined by the NH2-terminal transmembrane span-
ning domain (Price et al., 1996). In addition, the HXH-
CFTR chimera was sensitive to PKC stimulation, indicat-
ing that the R domain is the target for the activation of
XCFTR by PKC stimulation, and that the Xenopus R do-
main is sufﬁcient to confer sensitivity of CFTR to PKC
stimulation. These experiments also indicate that the
interaction between the R domain and other regions of
CFTR is preserved in the HXH chimera. Although the
human and Xenopus R domains exhibit only 65% amino
acid sequence identity, the Xenopus R domain does in-
teract with the nucleotide-binding domains and/or
transmembrane domains of hCFTR, eliciting channel
activation in response to PKA stimulation.
The mutagenesis experiments presented in this pa-
per indicate that the PKC consensus phosphorylation
site including Thr665 is required for the activation of
the channel by PKC stimulation. In hCFTR, Thr665 is
conserved, but the PKC consensus phosphorylation site
is missing. Insertion of this site in the H667R-hCFTR
mutant resulted in a large increase in current in re-
sponse to PKC activation. The experiments on this mu-
tant and the HXH chimera were different in some re-
spects (e.g., priming concentration of 8-Br-cAMP and
amount of cRNA injected), making a quantitative com-
parison of the responses to PKC activation difﬁcult. In
any event, the results indicate that the PKC consensus
phosphorylation site that includes Thr665 is critical for
the response to PMA. If the activation of the H667R-
hCFTR mutant is in fact less than that of the HXH chi-
mera, then one would conclude also that the phosphor-
ylation of Thr665, or its functional effect, involves other
residues of the R domain of CFTR.
PKC-mediated activation of hCFTR requires endoge-
nous phosphorylation by PKA (Yamazaki et al., 1999).
Activation of XCFTR by PMA occurred in all oocytes in
the absence of priming, whereas HXH-CFTR needed
priming (Figs. 2 and 4). This difference could be the re-
sult of either a lower PKA-mediated phosphorylation of
HXH-CFTR at basal cAMP levels, or differences in the in-
teraction of the R domain of XCFTR with other hCFTR
domains. Oocytes expressing a chimera consisting of the
R domain and COOH-terminal half of XCFTR and the
NH2-terminal half of hCFTR did not require priming,
whereas a CFTR molecule consisting of the NH2-termi-
nal half and R domain of XCFTR and the COOH-termi-
nal half of hCFTR did (Button et al., 2000). Additional
studies will be needed to establish the bases of the need
for priming of the HXH-CFTR.
Our data suggest, but do not prove, that the stimula-
tion of XCFTR by PMA is directly mediated by phosphor-
ylation of Thr665 by PKC. This is the simplest explana-
tion of our results because of the following reasons.
First, the inactive phorbol ester 4a-PMA is ineffective,
ruling out most nonspeciﬁc effects of PMA. Second,
PMA treatment does not increase cAMP levels in oo-
cytes, ruling out an indirect effect via PKA activation.
Third, cGMP is ineffective in Necturus gallbladder epi-
thelial cells (Heming et al., 1994), suggesting no role of
the cGMP-dependent kinase in the regulation of am-
phibian CFTR. Fourth, substitution of Thr665 in a PKC
consensus phosphorylation site of XCFTR abolishes the
response to PMA. Finally, addition of a PKC consensus
phosphorylation site in hCFTR confers sensitivity of this
molecule to PMA. Based on these observations, we hy-
pothesize that phosphorylation of Thr665 by PKC is re-
sponsible for the activation of XCFTR by PMA. The
phosphorylation level of CFTR depends on the rates of
phosphorylation and dephosphorylation. Thus, it is
conceivable that PMA may inhibit a phosphatase that
dephosphorylates Thr665, and this inhibition solely or in
part could account for the increase in phosphorylation
of Thr665. Resolution of the precise mechanism of
XCFTR activation will require additional experiments.
Figure 10. PMA produces a large increase in conductance in a
mutant hCFTR (H667R-hCFTR) with an engineered PKC consen-
sus phosphorylation sequence that includes Thr665. (A) Represen-
tative I-V plot from an oocyte expressing H667R-hCFTR. (B) Sum-
mary of results from experiments such as those in A. Oocytes were
primed with 25 mM 8-Br-cAMP. Data were obtained from six exper-
iments. The results indicate that the engineered PKC consensus
site is sufﬁcient to confer a large response to PKC stimulation.466 Regulation of CFTR by PKC-mediated Phosphorylation
The Mechanism of CFTR Activation by Phosphorylation
of the R Domain
It is clear that hCFTR is activated by PKA-mediated
phosphorylation of residues located mainly in the R do-
main (Anderson et al., 1991; Tabcharani et al., 1991;
Nagel et al., 1992). Phosphorylation of speciﬁc residues
can modulate CFTR either positively or negatively
(Wilkinson et al., 1997), but mutagenesis studies indi-
cate that no single site is responsible for the activation
(Cheng et al., 1991; Chang et al., 1993; Rich et al.,
1993). Therefore, it is thought that the increase in
CFTR channel open probability by PKA activation is a
consequence of either a change in the net charge of
the R domain (Ostedgaard et al., 2000) or a more com-
plicated phenomenon involving multiple phosphoryla-
tion consensus sites (Gadsby and Nairn, 1999; Baldurs-
son et al., 2000). In contrast, our data indicate that a
speciﬁc residue (Thr665) is necessary for the activation
of the XCFTR channel by PMA.
It has been assumed that exon 13 of hCFTR (residues
591–830) codes for the R domain (Cheng et al., 1991).
However, recent experimental evidence suggests that
exon 13 includes three distinct regions. The ﬁrst re-
gion is the last portion of the ﬁrst nucleotide-binding
domain (Chan et al., 2000), based on the homology be-
tween CFTR and the ATP-binding subunit of the histi-
dine permease (Hung et al., 1998). The second region
is the NH2-terminal region of the R domain, which con-
tains few consensus phosphorylation sites, but includes
Thr665, the critical residue for activation of XCFTR by
PKC stimulation. This region is somewhat structured
and phosphorylation by PKA probably changes its sec-
ondary structure (Dulhanty and Riordan, 1994). The
third region is the COOH-terminal region of the R do-
main, which contains most PKA and PKC phosphoryla-
tion sites. This region is mostly made of random coils,
and PKA-mediated phosphorylation has no effect on its
secondary structure, which was assessed by circular
dichroism spectroscopy (Ostedgaard et al., 2000). Our
results are compatible with the notion that activation of
CFTR by PKC stimulation involves the more structured
NH2-terminal region of the R domain and occurs inde-
pendently of the net charge. Consistent with this view, a
chimera in which part of the COOH-terminal portion
of the R domain of hCFTR was replaced with the linker
domain of MDR1 was fully activated by PKA (Vankeer-
berghen et al., 1999). Although the linker region of
MDR1 has three sites known to be phosphorylated by
PKC, stimulation of this kinase did not increase chan-
nel activity signiﬁcantly (Vankeerberghen et al., 1999).
These observations support the conclusion that activa-
tion of CFTR by PKC stimulation depends on the spe-
ciﬁc location of the phosphorylated residue. The dem-
onstration that a single residue is critical for CFTR acti-
vation by PKC stimulation provides basic and novel
information that will serve for future studies aimed at
understanding CFTR regulation at the structural level.
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